Guttmacher Institute Urges FDA to Uphold Mifepristone Access Amidst Misinformation
2025-11-08
PubComNonGov2025-11-08
Carter Struck
WASHINGTON, Nov. 8 -- The Guttmacher Institute, New York, has submitted a public comment letter to the Food and Drug Administration (FDA) advocating for the maintenance of access to mifepristone, a me . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, Nov. 8 -- The Guttmacher Institute, New York, has submitted a public comment letter to the Food and Drug Administration (FDA) advocating for the maintenance of access to mifepristone, a me . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
Copyright © Targeted News Service, 2025